RecruitingNot Applicable

StableEyes With Active Neurofeedback

United States48 participantsStarted 2022-08-08

Plain-language summary

The investigators have developed a self-administered rehabilitation tool that incrementally guides the user to increase head motion to mitigate motion sickness and enhance postural recovery following centrifugation or unilateral vestibular nerve deafferentation surgery.

Who can participate

Age range21 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Provision of signed and dated informed consent form
✓. Stated willingness to comply with all study procedures and availability for the duration of the study
✓. In good general health as evidenced by medical history or diagnosed with unilateral vestibular schwannoma
✓. Willing to adhere to the SWAN and/or vestibular rehabilitation regimen

Exclusion criteria

✕. Current use of anti-nausea medication
✕. Presence of cervical spine pathology that limits head motion to \< 30 degrees in the horizontal or vertical plane (i.e. degenerative disc disease, rheumatoid arthritis)
✕. Any orthopedic pathology that prevents walking or standing independently (i.e. recent surgery)
✕. Legal blindness (20/200 or worse visual acuity)
✕. Treatment using a motion sickness investigational drug or other motion sickness behavioral intervention within 30 days

What they're measuring

Change in Motion sickness intensity as assessed by subjective rating

Timeframe: Daily for up to 4 weeks

Trial details

NCT IDNCT05622344

SponsorJohns Hopkins University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-09-30

Contact for this trial

Michael Schubert, PhD

4108427403 mschube1@jhmi.edu

View on ClinicalTrials.gov More Vestibular Disorder trials